Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: Development of a [3.3.0]-based series and other piperidine bioisosteres

Douglas J. Sheffler, Michael T. Nedelovych, Richard Williams, Stephen C. Turner, Brittany B. Duerk, Megan R. Robbins, Sataya B. Jadhav, Colleen M. Niswender, Carrie K. Jones, P. Jeffrey Conn, R. Nathan Daniels, Craig W. Lindsley

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

8 Citations
1 Comment/debate

1 results

2017

Corrigendum to “Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: Development of a [3.3.0]-based series and other piperidine bioisosteres” [Bioorg. Med. Chem. Lett. 24 (2014) 1062–1066]
Sheffler, D. J., Nedelcovych, M. T., Williams, R., Turner, S. C., Duerk, B. B., Robbins, M. R., Jadhav, S. B., Niswender, C. M., Jones, C. K., Jeffrey Conn, P., Nathan Daniels, R. & Lindsley, C. W., 24 Mar 2017, In: Bioorganic and Medicinal Chemistry Letters. 27, 9, p. 2079 1 p.
Research output: Contribution to journal › Comment/debate › peer-review

Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: Development of a [3.3.0]-based series and other piperidine bioisosteres

Research output

Search results

Corrigendum to “Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: Development of a [3.3.0]-based series and other piperidine bioisosteres” [Bioorg. Med. Chem. Lett. 24 (2014) 1062–1066]